Diabetes News Archive

WASHINGTON Federal health scientists have panned a GlaxoSmithKline study that the company used to defend the safety of its embattled diabetes drug Avandia, a once blockbuster-seller that has fallen out of favor because of potential ties to heart attacks.

WASHINGTON - A review by federal health scientists reinforces potential ties between the diabetes pill Avandia...

New federal analyses released Friday raised additional questions about the safety of the controversial diabetes drug Avandia. Food and Drug Administration - GlaxoSmithKline - United States - Avandia - Health

Olympic cross-country skier Kris Freeman visited with kids Friday at Camp Endres in Guthrie to share his story of overcoming diabetes and working toward his dreams.

A widely-used diabetes drug may be taken off the market in Europe and the United States.

The popular diabetes drug Avandia may be far more dangerous to patients than reported in a study touted by the drug's manufacturer, according to a strongly worded report posted Friday by the Food and Drug Administration.

GlaxoSmithKline's blockbuster diabetes treatment Avandia suffered a new setback Friday when US health officials offered more evidence of the drug's increased link to heart problems.

iPod Touch, Diabetes Drug, Wells Fargo, LeBron James, Dan Gilbert and Miami Heat are the trending topics on Google and Yahoo.

Pressure on GlaxoSmithKline's diabetes drug, Avandia, mounts as a scientist from America's Food and Drug Administration questions the conduct of a trial into risks to the heart.

Gestational diabetes is a form of glucose intolerance diagnosed during pregnancy.

A document released today by the U.S. Food and Drug Administration (FDA) concludes that, as critics have claimed since 2006, the hugely popular diabetes drug Avandia (rosiglitizone) increases the risk for heart attack. The 765-page briefing document released today in anticipation of an advisory panel meeting on July 13-14 to determine whether the drug should [...]

As the Juvenile Diabetes Research Foundation's largest and most successful event, the Walk to Cure Diabetes brings together corporations, families, friends and schools to walk three miles in support of the three million Americans living with type 1 diabetes.

Gestational Diabetes

A review by federal health scientists reinforces potential ties between the diabetes pill Avandia and heart attack and death, opening the door for government action, including a possible withdrawal of the once blockbuster drug. Food and Drug Administration - Health - Pharmaceutical drug - Conditions and Diseases - Myocardial infarction

A review by federal health scientists reinforces potential ties between the diabetes pill Avandia and heart attack and death, opening the door for government action, including a possible withdrawal of the once blockbuster drug. Food and Drug Administration - Health - Pharmaceutical drug - Conditions and Diseases - Myocardial infarction

An internal agency battle comes to light as FDA scientists say the popular diabetes drug is too risky to remain on the market.

A review by federal health scientists reinforces potential ties between the diabetes pill Avandia and heart attack and death, opening the door for government action, including a possible withdrawal of the once blockbuster drug.

MADISON - Ever since Casey Carr, 9, was diagnosed with Type 1 diabetes last December, she has been on a mission to get the word out to other children who might have the same condition:

A common test to diagnose gestational diabetes - a temporary condition which can harm both mother and child if left untreated - also has predictive power for Type II adult-onset diabetes, a new Tel Aviv University study finds. Dr. Gabriel Chodick of Tel Aviv University's Department of Epidemiology and Preventive Medicine at the Sackler Faculty of Medicine has proven that women who "fail" the ...

Children born to mothers who had transient diabetes during pregnancy face heightened risk of long-term metabolic complications, the Chinese University of Hong Kong has found.